미국의 동물용 POC(Point of Care) 진단 시장 규모, 점유율, 동향 분석 보고서 : 제품 유형별, 동물 유형별, 샘플 유형별, 적응증별, 검사 카테고리별, 최종 용도별, 국가별, 부문별 예측(2025-2030년)

Market Size & Trends:

The U.S. veterinary point-of-care diagnostics market size was valued at USD 1.04 billion in 2024 and is estimated to grow at a CAGR of 9.2% from 2025 to 2030. The market's growth is predominantly fueled by a surge in spending on pet-related products and services, an expanding number of pet owners, technological advancements, and a strong demand for point-of-care diagnostics.

The rise in the companion animal population is anticipated to drive demand for veterinary healthcare services and increase overall pet spending. Pet owners in the U.S., according to 2024 statistics published by the American Pet Products Association (APPA), are estimated to be spending more than USD 150 billion on their pets, about a 66% rise from the USD 90.5 billion expenditure in 2018. Furthermore, pet owners in the country are estimated to spend about USD 39 billion on veterinary care services & products in 2024. Diagnostic tests like point-of-care (POC) provide immediate results and clinically relevant information without needing a core diagnostic laboratory. Therefore, they can reduce the cost and time associated with veterinary diagnosis. The lateral flow technology applied in POC veterinary lateral flow devices and dipsticks has been used for decades to diagnose infectious diseases among animals.

Moreover, the high number of veterinary patient visits and developed veterinary healthcare infrastructure are further expected to fuel the market growth. Companies are investing in R&D to develop point-of-care diagnostic equipment. For instance, IDEXX developed SDMA test kits, which use AI to assess kidney functions in cats and dogs. Zoetis has a pipeline of point-of-care diagnostics, which is expected to be launched in the coming years. Heska also launched a range of point-of-care diagnostic products to broaden its portfolio.

Another continuously evolving driver of this diagnostic sector is the emergence of novel technologiesfor advancing POC diagnostics in animals. For instance, researchers from Wyss Research Institute at Harvard College have developed a POC diagnostic technology, directEsense, for application in veterinary health. The technology simplifies the diagnostic process by utilizing an electrically active chemical layer on biosensor surfaces to directly detect disease biomarkers and pathogens and eliminates the need for detection labels; this product enhances electrical conductivity and reduces costs associated with traditional diagnostic methods. This research focuses on detecting unique blood serum proteins in companion animals suffering from musculoskeletal injuries and infections. The parties are now aiming for efficient product development and potential future human and environmental health diagnostics applications.

Furthermore, some other advancements, like artificial intelligence (AI), which enhances the speed and accuracy of diagnoses through real-time analysis of medical data, such as X-rays and blood tests, are expected to act as catalysts for future industry growth. Molecular diagnostics facilitate early disease detection by identifying specific pathogens and genetic markers, facilitating personalized medicine tailored to individual animals.

U.S. Veterinary Point of Care Diagnostics Market Report Segmentation

This report forecasts revenue growth at the country level and provides an analysis of the latest trends and opportunities in each of the sub-segments from 2018 to 2030. For this report, Grand View Research has segmented the U.S. intravenous infusion pump market based on product, animal type, sample type, indication, testing category, and end-use:

• Product Outlook (Revenue, USD Million, 2018 - 2030)
• Consumables, Reagents, & Kits
• Instruments & Devices
• Animal Type Outlook (Revenue, USD Million, 2018 - 2030)
• Companion Animals
  • Dogs
  • Cats
  • Horses
  • Others
• Livestock Animals
  • Cattle
  • Swine
  • Poultry
• Sample Type Outlook (Revenue, USD Million, 2018 - 2030)
• Blood/Plasma/Serum
• Urine
• Fecal
• Others
• Indication Outlook (Revenue, USD Million, 2018 - 2030)
• Infectious Disease
• General Ailments
• Others
• Testing Category Outlook (Revenue, USD Million, 2018 - 2030)
• Hematology
• Diagnostic Imaging
• Bacteriology
• Virology
• Cytology
• Clinical Chemistry
• Parasitology
• Serology
• Others
• End-Use Outlook (Revenue, USD Million, 2018 - 2030)
• Veterinary Hospitals & Clinics
• Home Care Settings
• Others

Table of Contents

Chapter 1. Methodology and Scope

• 1.1. Market Segmentation & Scope
• 1.2. Segment Definitions
  • 1.2.1. Product
  • 1.2.2. Animal Type
  • 1.2.3. Sample Type
  • 1.2.4. Indication
  • 1.2.5. Testing category
  • 1.2.6. End-use
• 1.3. Research Methodology
• 1.4. Information Procurement
  • 1.4.1. Purchased database
  • 1.4.2. GVR's internal database
  • 1.4.3. Secondary sources
  • 1.4.4. Primary research
  • 1.4.5. Details of primary research
    • 1.4.5.1. Data for primary interviews in Italy
• 1.5. Information or Data Analysis
  • 1.5.1. Data analysis models
• 1.6. Market Formulation & Validation
• 1.7. Model Details
  • 1.7.1. Commodity flow analysis (Model 1)
  • 1.7.2. Approach 1: Commodity flow approach
  • 1.7.3. Volume price analysis (Model 2)
  • 1.7.4. Approach 2: Volume price analysis
• 1.8. List of Secondary Sources
• 1.9. List of Primary Sources
• 1.10. Objectives

Chapter 2. Executive Summary

• 2.1. Market Outlook
• 2.2. Segment Outlook
  • 2.2.1. Product
  • 2.2.2. Disease Indication
• 2.3. Competitive Insights

Chapter 3. U.S. Veterinary point of care diagnostics Market Variables, Trends, & Scope

• 3.1. Market Lineage Outlook
  • 3.1.1. Parent market outlook
  • 3.1.2. Related/ancillary market outlook
• 3.2. Market Dynamics
• 3.3. Market Driver Analysis
  • 3.3.1. Increasing Pet-Related Expenditures
  • 3.3.2. Technological Advancements
  • 3.3.3. Increasing Demand for Point-Of-Care Diagnostics
  • 3.3.4. Rising Livestock Population and Pet Ownership
• 3.4. Market Restraint Analysis
  • 3.4.1. Economic Differences in Developed & Developing Markets
  • 3.4.2. Unstructured And Lenient Rules & Regulations
  • 3.4.3. Time-Consuming R&D Processes and Higher Investments
• 3.5. Industry Analysis - Porter's Five Forces
  • 3.5.1. Supplier power
  • 3.5.2. Buyer power
  • 3.5.3. Substitution threat
  • 3.5.4. Threat of new entrant
  • 3.5.5. Competitive rivalry
• 3.6. PESTEL Analysis
  • 3.6.1. Political landscape
  • 3.6.2. Technological landscape
  • 3.6.3. Economic Landscape
• 3.7. Technology Evolution Analysis
• 3.8. Estimated Animal Population, by Key Species, 2018 - 2024
• 3.9. Regulatory Scenario
• 3.10. COVID-19 Impact Analysis

Chapter 4. U.S. Veterinary point of care diagnostics Market Product Estimates & Trend Analysis

• 4.1. U.S. Veterinary point of care diagnostics Market Product Dashboard
• 4.2. U.S. Veterinary point of care diagnostics Market Product Movement Analysis
• 4.3. U.S. Veterinary point of care diagnostics Market Size & Forecasts and Trend Analyses, 2018 to 2030
• 4.4. Consumables, Reagents, & Kits
• 4.5. Consumables, Reagents, & Kits Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
  • 4.5.1. Instruments & Devices
  • 4.5.2. Instruments & Devices Market Estimates and Forecasts, 2018 - 2030 (USD Billion)

Chapter 5. U.S. Veterinary point of care diagnostics Market: Animal Type Outlook Estimates & Trend Analysis

• 5.1. U.S. Veterinary point of care diagnostics Animal Type Model Dashboard
• 5.2. U.S. Veterinary point of care diagnostics Market Animal Type Movement Analysis
• 5.3. Livestock
  • 5.3.1. Livestock Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• 5.4. Poultry
  • 5.4.1. Poultry Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• 5.5. Cattle
  • 5.5.1. Cattle Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• 5.6. Swine
  • 5.6.1. Swine Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• 5.7. Others
  • 5.7.1. Others Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• 5.8. Companion Animals
  • 5.8.1. Companion Animals Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• 5.9. Dogs
  • 5.9.1. Dogs Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• 5.10. Cats
  • 5.10.1. Cats Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• 5.11. Horses
  • 5.11.1. Horses Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• 5.12. Others
  • 5.12.1. Others Market Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 6. U.S. Veterinary point of care diagnostics Market Sample Type Estimates & Trend Analysis

• 6.1. U.S. Veterinary point of care diagnostics Sample Type Model Dashboard
• 6.2. U.S. Veterinary point of care diagnostics Market Sample Type Movement Analysis
• 6.3. Blood/Plasma/Serum
  • 6.3.1. Blood/Plasma/Serum Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• 6.4. Urine
  • 6.4.1. Urine Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• 6.5. Fecal
  • 6.5.1. Fecal Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• 6.6. Others
  • 6.6.1. Others Market Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 7. U.S. Veterinary point of care diagnostics Market Indication Estimates & Trend Analysis

• 7.1. U.S. Veterinary point of care diagnostics Indication Model Dashboard
• 7.2. U.S. Veterinary point of care diagnostics Market Indication Movement Analysis
• 7.3. Infectious Disease
  • 7.3.1. Infectious Disease Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• 7.4. General Ailments
  • 7.4.1. General Ailments Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• 7.5. Others
  • 7.5.1. Others Market Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 8. U.S. Veterinary point of care diagnostics Market Testing Category Estimates & Trend Analysis

• 8.1. U.S. Veterinary point of care diagnostics Testing Category Model Dashboard
• 8.2. U.S. Veterinary point of care diagnostics market testing Category Movement Analysis
• 8.3. Testing Category Dashboard
• 8.4. Hematology
  • 8.4.1. Hematology Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• 8.5. Diagnostic Imaging
  • 8.5.1. Diagnostic Imaging Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• 8.6. Bacteriology
  • 8.6.1. Bacteriology Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• 8.7. Virology
  • 8.7.1. Virology Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• 8.8. Cytology
  • 8.8.1. Cytology Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• 8.9. Clinical Chemistry
  • 8.9.1. Clinical Chemistry Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• 8.10. Parasitology
  • 8.10.1. Parasitology Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• 8.11. Serology
  • 8.11.1. Serology Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• 8.12. Others
  • 8.12.1. Others Market Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 9. U.S. Veterinary point of care diagnostics Market End-use Estimates & Trend Analysis

• 9.1. U.S. Veterinary point of care diagnostics Testing Category Model Dashboard
• 9.2. U.S. Veterinary point of care diagnostics market testing Category Movement Analysis
• 9.3. Veterinary Hospitals & Clinics
  • 9.3.1. Veterinary Hospitals & Clinics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• 9.4. Home Care Settings
  • 9.4.1. Home Care Settings Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• 9.5. Others
  • 9.5.1. Others Market Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 10. Competitive Landscape

• 10.1. Recent Developments & Impact Analysis, By Key Market Participants
• 10.2. Company/Competition Categorization
  • 10.2.1. Vendor Landscape
  • 10.2.2. List of key distributors and channel partners
  • 10.2.3. Key customers
  • 10.2.4. Key company market share analysis, 2024
• 10.3. Zoetis Inc.
  • 10.3.1. Company Overview
  • 10.3.2. Financial performance
  • 10.3.3. Product Benchmarking
  • 10.3.4. Strategic initiatives
• 10.4. Thermo Fisher Scientific Inc
  • 10.4.1. Company Overview
  • 10.4.2. Financial performance
  • 10.4.3. Product Benchmarking
  • 10.4.4. Strategic initiatives
• 10.5. Heska Corporation
  • 10.5.1. Company Overview
  • 10.5.2. Financial performance
  • 10.5.3. Product Benchmarking
  • 10.5.4. Strategic initiatives
• 10.6. Phibro Animal Health Corporation
  • 10.6.1. Company Overview
  • 10.6.2. Financial performance
  • 10.6.3. Product Benchmarking
  • 10.6.4. Strategic initiatives
• 10.7. Blair Milling and Elevator Co., Inc.
  • 10.7.1. Company Overview
  • 10.7.2. Financial performance
  • 10.7.3. Product Benchmarking
  • 10.7.4. Strategic initiatives
• 10.8. NeuroLogica Corp
  • 10.8.1. Company Overview
  • 10.8.2. Financial performance
  • 10.8.3. Product Benchmarking
  • 10.8.4. Strategic initiatives
• 10.9. NEOGEN Corporation
  • 10.9.1. Company Overview
  • 10.9.2. Financial performance
  • 10.9.3. Product Benchmarking
  • 10.9.4. Strategic initiatives
• 10.10. Marshfield Labs
  • 10.10.1. Company Overview
  • 10.10.2. Financial performance
  • 10.10.3. Product Benchmarking
  • 10.10.4. Strategic initiatives
• 10.11. ProtaTek International, Inc.
  • 10.11.1. Company Overview
  • 10.11.2. Financial performance
  • 10.11.3. Product Benchmarking
  • 10.11.4. Strategic initiatives
• 10.12. Texas A&M Veterinary Medical Diagnostic Laboratory
  • 10.12.1. Company Overview
  • 10.12.2. Financial performance
  • 10.12.3. Product Benchmarking
  • 10.12.4. Strategic initiatives
• 10.13. VCA, Inc
  • 10.13.1. Company Overview
  • 10.13.2. Financial performance
  • 10.13.3. Product Benchmarking
  • 10.13.4. Strategic initiatives
• 10.14. IDEXX
  • 10.14.1. Company Overview
  • 10.14.2. Financial performance
  • 10.14.3. Product Benchmarking
  • 10.14.4. Strategic initiatives
• 10.15. University of Minnesota
  • 10.15.1. Company Overview
  • 10.15.2. Financial performance
  • 10.15.3. Product Benchmarking
  • 10.15.4. Strategic initiatives